Cargando…
Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
Chagas disease affects about 5 million people across the world. The etiological agent, the intracellular parasite Trypanosoma cruzi (T. cruzi), can be diagnosed using microscopy, serology or PCR based assays. However, each of these methods has their limitations regarding sensitivity and specificity,...
Autores principales: | Nagarkatti, Rana, de Araujo, Fernanda Fortes, Gupta, Charu, Debrabant, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894185/ https://www.ncbi.nlm.nih.gov/pubmed/24454974 http://dx.doi.org/10.1371/journal.pntd.0002650 |
Ejemplares similares
-
Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
por: de Araujo, Fernanda Fortes, et al.
Publicado: (2015) -
Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood
por: Nagarkatti, Rana, et al.
Publicado: (2012) -
A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease
por: Nagarkatti, Rana, et al.
Publicado: (2020) -
A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
por: Silberstein, Erica, et al.
Publicado: (2018) -
Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022)